Over the last few years, we’ve been covering the ongoing testing of a blood pressure management system from CVRx out of Minneapolis, MN. The Rheos Baroreflex Hypertension Therapy System is an ...

April 8, 2011 (New Orleans, Louisiana) — Mixed results from a so-called "pivotal" trial of a new pacemakerlike device for the treatment of highly resistant hypertension, the Rheos system (CVRx, ...

CVRx Inc. in Plymouth, Minn. said Monday that hypertension patients using its Rheos stimulation device reported a sharp drop in blood pressure after four years. In a study presented to the European ...

June 21, 2010 (Minneapolis, Minnesota and Oslo, Norway) — The future of the Rheos system (CVRx, Minneapolis, MN) in patients with resistant hypertension is hanging in the balance after a data safety ...

Can your brain control your blood pressure? Surgeons recently implanted the RheosR System into the first clinical trial patient. When the device was turned on, the patient's blood pressure ...

In one of the biggest venture capital deals in Minnesota in recent years, Brooklyn Park-based CVRx said it has raised $84 million to fund continued development of a medical device implant to treat ...

MINNEAPOLIS, Nov. 14 (UPI) -- U.S. device maker CVRx said Tuesday new data show its Rheos Baroreflex Hypertension Therapy System greatly reduces blood pressure. The privately held company said early ...

Patients suffering from severe hypertension and those who cannot control their conditions with medications need not worry now --- a new device system is being introduced for their rescue. The new ...

– Preclinical data demonstrate MALT1 inhibition targets pathogenic activity of the activated immune system, showing efficacy in a model of cGVHD – – Metabolomic analysis reveals an induction of the ...

– Preclinical data demonstrate that MALT1 inhibitors targeting the anabolic hub modulate key drivers of disease and are efficacious in multiple inflammatory disease models – – Rheos is developing ...

In people with severe hypertension, this experimental device can trigger the body’s natural blood flow regulation system to lower high blood pressure and prevent heart failure. “Current drugs and ...

NORWALK, Conn. and TOKYO, Japan, Oct. 06, 2022 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading ...